Immunoglobulin therapy for plasma cell-rich rejection in the renal allograft

Transplantation

Volumn 82, Issue 4, 2006, Pages 567-569

  Adrogue, Horacio E ^a,b   Soltero, Liliana ^a   Land, Geoffrey A ^a   Ramanathan, Venkataraman ^a   Truong, Luan D ^b   Suki, Wadi N ^c  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Kidney Institute   (United States)

Author keywords

Antibodies; Graft loss; Humoral rejection; Intravenous immunoglobulin; Plasmapheresis

Indexed keywords

IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL MATURATION; COLITIS; CYTOMEGALOVIRUS INFECTION; DIARRHEA; FEMALE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NEUTROPENIA; PLASMA CELL; PLASMA CELL RICH ACUTE REJECTION; PLASMAPHERESIS; PRIORITY JOURNAL;

ADULT; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33747888751     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000231922.11453.ec     Document Type: Article

References (9)

1. Desvaux D, Le Gouvello S, Pastural M, et al. Acute renal allograft rejections with major interstitial oedema and plasma cell-rich infiltrates: high gamma-interferon expression and poor clinical outcome. Nephrol Dial Transplant 2004; 19: 933.
2. Meehan SM, Domer P, Josephson M, et al. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol 2001; 32: 205.
3. Charney DA, Nadasdy T, Lo AW, Racusen LC. Plasma cell-rich acute renal allograft rejection. Transplantation 1999; 68: 791.
4. Nadasdy T, Krenacs T, Kalmar KN, et al. Importance of plasma cells in the infiltrate of renal allografts. Path Res Pract 1991; 187: 178.
5. Suzuki T, Fukuzawa J, Furuya S, et al. Renal graft loss with plasma cell-rich acute rejection in cadaveric renal transplantation: a case report. Clin Transplant 2005; 19 Suppl 14: 71.
6. David-Nieto E, Ribeiro DS, Ianhez LE, et al. Acute interstitial nephritis of plasma cells: a new cause for renal allograft loss. Transplant Proceedings 1993; 25: 897.
7. Montgomery RA, Hardy MA, Jordan SC, et al. Consensus Opinion from the Antibody Working Group on the Diagnosis, Reporting, and Risk Assessment for Antibody-Mediated Rejection and Desensitization Protocols. Transplantation 2004; 78: 181.
8. Glotz D, Antoine C, Julia P, et al. Desensitization and subsequent kidney transplant of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2002; 2: 758.
9. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001; 345: 747.